NovaDigm Therapeutics

The first vaccine to demonstrate efficacy in reducing the mortality of otherwise highly lethal bloodstream infections due to either Candida or S. aure...

Start Trial Get Full Profile

There’s no risk. Start your trial today to see profiles of NovaDigm Therapeutics plus 5267 other startups.

Start Free 7 Day Trial Now

Learn More About NovaDigm Therapeutics

Technology/product details

Revenue projections

Capital raised to date

Growth strategy

Competing Startups

More

Our Clients